Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
Diagnostic, Prognostic and Predictive Biological Markers in Bladder Cancer - Illumination of a Vision 2.0
| Diagnostic, Prognostic and Predictive Biological Markers in Bladder Cancer - Illumination of a Vision 2.0 |
| Autore | Ecke Thorsten |
| Pubbl/distr/stampa | Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021 |
| Descrizione fisica | 1 online resource (240 p.) |
| Soggetto topico | Medicine |
| Soggetto non controllato |
adjuvant chemotherapy
androgen receptor BCG therapy biomarker biomarkers BIRC5 bladder bladder cancer bladder cancer detection cadmium exposure cancer chemotherapy combination therapy DNA methylation drug resistance ECRG4 ERBB2 F-actin FGFR3 grade heparan sulfate proteoglycans (HSPGs) heparanase histone demethylase immunotherapy invasion ITIH5 JAK inhibitor JAK-STAT pathway KDM7A KRT20 macrophage metabolomics Metallothionein MIBC miRNA MS muscle-invasive bladder cancer n/a NMR non muscle invasive bladder cancer non-invasive detection oncolytic adenovirus p53 personalized medicine prediction predictive biomarker prognosis proliferation PTEN quantitative PCR RT-qPCR somatic mutations STAT3/5 inhibitor survival survivin syndecan-1 TAGLN TC-E 5002 telomerase TERT promoter mutations TERT promoter region tumor marker tumor markers tumorigenesis urinary biomarkers urothelial cancer urothelial carcinoma urothelium virotherapy voided urine cytology XVir-N-31 zinc transporter |
| Formato | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910557142003321 |
Ecke Thorsten
|
||
| Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Updates on Molecular Targeted Therapies for CNS Tumors
| Updates on Molecular Targeted Therapies for CNS Tumors |
| Pubbl/distr/stampa | MDPI - Multidisciplinary Digital Publishing Institute, 2023 |
| Descrizione fisica | 1 online resource (368 p.) |
| Soggetto topico |
Medicine and Nursing
Oncology |
| Soggetto non controllato |
A172
A2AAR antagonist adenosine adenosine receptors antigen processing and presentation antioxidant apoptosis ATRX bevacizumab biomarker blood-brain barrier brain metastasis brain tumor cancer metabolism cell cycle arrest central nervous system chemotherapy CNS disease CNS lymphoma CpG island diffuse midline gliomas DNMT EGFR ependymoma EPHB2 epidermal growth factor receptor ERK/MAPK pathway FGFR3 G-CIMP GBM germline mutation glioblastoma glioblastoma molecular classification glioma Group A Group B H3K27M histone acetylation IDH-mutant glioma immune evasion immune score immunotherapy intraparenchymal metastases intrathecal isotope labeling KIF11 leptomeningeal low grade glioma low-grade glioma LPS lung cancer lung carcinoma lung malignancy mass spectrometry meningitis MET metastatic disease Metformin methotrexate methylation methylomics methyltransferases MGMT molecular targets molecular therapy monoclonal antibodies MYCN myxopapillary n/a neoantigen neoplastic neurofibromatosis NF1 novel therapeutics novel therapies patient avatars PCNSL PDGFRA pediatric brain tumor PFA PFB PI3K/PTEN pathway plexiform neurofibroma potential therapy development preclinical models progression progression-free survival radiotherapy receptor tyrosine kinase RELA stereotactic radiosurgery subependymoma T cells T lymphocytes targeted therapy temozolomide tumor microenvironment tumor mutation burden tumor suppressor tyrosine kinase inhibitors U87MG vestibular schwannoma Warburg effect whole-brain radiation therapy YAP1 ZFTA |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9911053032003321 |
| MDPI - Multidisciplinary Digital Publishing Institute, 2023 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||